Characteristics | Values |
---|---|
Age, years | 38.8 (0.51) |
Gender, male (%) | 127 (66.5) |
BMI, kg/m 2 | 22.93 (0.26) |
Current smokers, n (%) | 154 (80.6) |
Lipodystrophy, n (%) | 47 (24.1) |
Time of sero-prevalence, years | 4.29 (0.3) |
Risk factors for HIV, n (%) | |
Intravenous drug users | 113 (59.2) |
Heterosexual contact | 54 (28.3) |
Male homosexual contact | 24 (12.5) |
Treatment scheme, n (%) | |
Untreated | 51 (26.7) |
Non-nucleoside analogues | 76 (39.8) |
Protease inhibitors | 64 (33.5) |
Undetectable HIV-1 viral load a , n (%) | 114 (59.7) |
CD4+ T lymphocyte count, cells/mL | 459 (22.8) |
HCV co-infection, n (%) | 115 (60.2) |
HCV genotypes, % | |
I | 78.3 |
II | 3.8 |
III | 14.9 |
IV | 3.0 |
Log-HCV viral load, copies/mL | 5.89 (1.14) |